Effects of depressive disorders on coronary artery disease: A review

Harvard Review of Psychiatry

Volumn 5, Issue 3, 1997, Pages 115-122

  Dwight, Megan M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; WARFARIN;

BRADYCARDIA; COMORBIDITY; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; ELECTROCONVULSIVE THERAPY; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REVIEW; SIDE EFFECT; WEIGHT GAIN;

EID: 0030840499     PISSN: 10673229     EISSN: None     Source Type: Journal    
DOI: 10.3109/10673229709000297     Document Type: Review

References (2)

1. Carney RM, Rich MW, TeVelde A, Saini J, Clark K, Jaffe AS. Major depressive disorder in coronary artery disease. Am J Cardiol 1987;60:1273-5.
2. Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R, et al. The nature and course of depression following myocardial infarction. Arch Intern Med 1989;149:1785-9.